J Frontier Co.,Ltd.
Stock Price Chart
2026/07/24 UpdatedPrice Trend
2026/07/24 UpdatedPrice & Trading Details
2026/07/24 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/07/01Financial Performance
2026/07/26 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥11,877M | ¥16,845M | ¥17,715M | ¥21,504M |
| Gross Profit | ¥5,399M | ¥7,117M | ¥8,333M | ¥9,574M |
| Operating Income | ¥731M | -¥1,816M | -¥605M | ¥294M |
| Pretax Income | ¥702M | -¥1,836M | -¥1,686M | ¥308M |
| Net Income | ¥401M | -¥1,900M | -¥2,101M | ¥88M |
| EPS | ¥86.68 | -¥410.60 | -¥429.05 | ¥17.21 |
| Operating Margin | 6.16% | -10.78% | -3.42% | 1.37% |
| Balance Sheet | ||||
| Total Assets | ¥6,099M | ¥7,241M | ¥11,412M | ¥9,173M |
| Total Equity | ¥4,137M | ¥2,477M | ¥1,140M | ¥1,406M |
| Total Liabilities | ¥1,963M | ¥4,763M | ¥10,273M | ¥7,767M |
| Cash | ¥2,956M | ¥1,648M | ¥1,813M | ¥2,170M |
| Interest-bearing Debt | ¥547M | ¥2,136M | ¥5,167M | ¥4,344M |
| Equity Ratio | 67.82% | 34.21% | 9.99% | 15.33% |
| D/E Ratio | 0.13 | 0.86 | 4.53 | 3.09 |
| Cash Flow | ||||
| Operating CF | -¥367M | -¥1,830M | -¥1,436M | ¥509M |
| Investing CF | -¥860M | -¥1,133M | -¥1,793M | ¥471M |
| Financing CF | ¥2,565M | ¥1,451M | ¥3,391M | -¥623M |
| Free CF | -¥377M | -¥1,935M | -¥1,545M | ¥447M |
| Efficiency | ||||
| ROE | 9.68% | -76.70% | -184.38% | 6.23% |
| ROA | 6.57% | -26.24% | -18.41% | 0.95% |
Latest IR Information
-
【J Frontier】Revised Online Medical Consultation Pricing Structure and Earnings Forecast｜2026-07-15
J Frontier has revised the pricing structure of its online medical consultation platform "SOKUYAKU" and announced earnings forecasts for 2027-05. The revision is expected to expand revenue and profit, with operating income projected to reach approximately ¥1,050 million in the...
Read more -
Full-Year Financial Results for May 2026 Fiscal Year | Sales of ¥22.2 billion (YoY +3.4%)
In the full-year financial results for May 2026, the company achieved sales of ¥22.2 billion and operating profit of ¥312 million. Both figures increased YoY by 3.4% and with improved profit margins, signaling stable growth and prospects for future expansion.
Read more -
J-Frontier Earnings Revision | Fiscal Year ending May 2026
J-Frontier revised its consolidated earnings forecast for the fiscal year ending May 2026, lowering projected sales to 22,235 million yen, and plans to record a goodwill amortization expense of 435 million yen as a special loss. Net profit is expected...
Read more
Latest News (5 items)
Company Information
About
J Frontier Co.,Ltd. engages in the healthcare sales, medical care sales, and healthcare marketing businesses in Japan. The company operates SOKUYAKU, a platform for online medical treatment, online medication guidance, home delivery of prescription drugs, and digital transformation support for medical institutions. The company also sells health foods, health, beauty, education, healing, medicine, and medical care products through mail order; and provides product sales promotion support services. In addition, it offers Internet advertising for medical institutions and healthcare-related companies; and web marketing, in-store and TV shopping distribution, BPO support for logistics, etc. J Frontier Co.,Ltd. was incorporated in 2008 and is based in Shibuya, Japan.
